CEO & Co-founder
Nithya Iyer Singh
Co-founder: 2123iX and 2123 FrontiersGSK, Tesaro and MedcoLinkedIn
About Elymus
Built across scientific
disciplines
Our team brings together expertise in macromolecular science, biomolecular engineering, deep knowledge of muscular dystrophy, cardiovascular disease, and drug development.
Leadership
Founders and executive leadership
GSK, Tesaro and MedcoLinkedIn
Co-founder · Regents Professor
Frank Bates
Chemical Engineering & Materials Science, University of MinnesotaLinkedIn
Co-founder · Professor
Ben Hackel
Chemical Engineering & Materials Science, University of MinnesotaLinkedIn
Co-founder · Regents Professor
Tim Lodge
Chemistry and Chemical Engineering & Materials Science, University of MinnesotaLinkedInAdvisors
Scientific, medical and business guidance
Professor: Dept. Head & Chair
Joe Metzger
Integrative Biology & Physiology, University of MinnesotaLinkedIn
Professor of Medicine
Demetris Yannopoulos, MD
Research Director: Interventional Cardiology; Director: Resuscitation MedicineLinkedIn
Business Advisor
Navjot (Nav) Singh
Co-founder & CEO: 2123iX, 2123QSenior Partner Emeritus, McKinseyLinkedIn
How we work
Rigorous by design
We connect fundamental molecular insight to biological performance through careful characterization, translational focus, and multidisciplinary collaboration.